１．英文原著

1.Adams D, Gonzalez-Duarte A, O’Riordan W, Yang C, Ueda M, Kristen A, Tournev I, Schmidt H, Coelho T, Berk J, Lin K, Vita G, Attarian S, Plante-Bordeneuve V, Mezei M, Campistol J, Buades J, Brannagan T, Kim B, Oh J, Parman Y, Sekijima Y, Hawkins P, Solomon S, Polydefkis M, Dyck P, Gandhi P, Goyal S, Chen J, Strahs A, Nochur S, Sweetser M, Garg P, Vaishnaw A, Gollob J, Suhr O:

Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis.

N Engl J Med, 379: 11-21, 2018 

2.Asahi T, Sato M, Nakamura T, Kon Y, Kajimoto H, Oyama G, Hayashi A, Tanaka K, Nakane S, Takeshima T, Fujii M, Kuroda S:

Pilot Study of a Device to Induce the Hanger Reflex in Patients with Cervical Dystonia.

Neurol Med Chir (Tokyo), 58: 206-211, 2018

3. Fukuda M, Yoshizawa T, Karim MF, Sobuz SU, Korogi W, Kobayasi D, Okanishi H, Tasaki M, Ono K, Sawa T, Sato Y, Chirifu M, Masuda T, Nakamura T, Tanoue H, Nakashima K, Kobashigawa Y, Morioka H, Bober E, Ohtsuki S, Yamagata Y, Ando Y, Oike Y, Araki N, Takeda S, Mizuta H, Yamagata K:

SIRT7 has a critical role in bone formation by regulating lysine acylation of SP7/Osterix.

Nat Commun, 9: 2833, 2018

4.Hamanaka K, Miyatake S, Koshimizu E, Tsurusaki Y, Mitsuhashi S, Iwama K, Alkanaq AN, Fujita A, Imagawa E, Uchiyama Y, Tawara N, Ando Y, Misumi Y, Okubo M, Nakashima M, Mizuguchi T, Takata A, Miyake N, Saitsu H, Iida A, Nishino I, Matsumoto N:

RNA sequencing solved the most common but unrecognized NEB pathogenic variant in Japanese nemaline myopathy.

Genet Med, 21: 1629-1938, 2019

5.Horio Y, Takamatsu K, Tamanoi D, Sato R, Saruwatari K, Ikeda T, Nakane S, Nakajima M, Saeki S, Ichiyasu H, Fujii K, Tomita Y:

Trousseau’s syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient.

Eur J Immunol, 48: 1764-1767, 2018

6.Ikeda T, Kakuma T, Watari M, Ando Y:

Fingolimod-induced decrease in heart rate may predict subsequent decreasing degree of lymphocytes.

Sci Rep, 8: 16430, 2018

7.Ikeda T, Masuda T, Ueda M, Yamashita T, Misumi Y, Shinriki S, Ando Y:

Unwanted road to anaemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatment.

Ann Clin Biochem, 55: 571-575, 2018

8.Kumai Y, Samejima Y, Yamashita S, Ando Y, Orita Y, Miyamoto T, Matsubara K:

Assessment of oropharyngeal swallowing dysfunction in myasthenia gravis patients presenting with difficulty in swallowing.

Auris Nasus Larynx, 46: 390-396, 2019

9.Masuda T, Ueda M, Kitajima M, Morita K, Misumi Y, Yamashita T, Obayashi K, Yamashita Y, Ando Y:

Teaching NeuroImages: Morphology of lumbosacral dorsal root ganglia and plexus in hereditary transthyretin amyloidosis.

Neurology, 91: e1834-e1835, 2018

10.Matsubara S, Koga M, Ohara T, Iguchi Y, Minatoya K, Tahara Y, Fukuda T, Miyazaki Y, Kajimoto K, Sakamoto Y, Makita N, Tokuda N, Nagatsuka K, Ando Y, Toyoda K:

Cerebrovascular imaging of cerebral ischemia in acute type A aortic dissection.

J Neurol Sci, 388: 23-27, 2018

11.Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C, (Yamashita T: 127^th collaborator):

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

N Engl J Med, 379: 1007-1016, 2018 

12.Mizutani H, Nakane S, Ikeda T, Nakamura H, Takamatsu K, Makino K, Tawara N, Mukaino A, Watari M, Matsui H, Mukasa A, Ando Y:

CSF TACI and BAFF levels in patients with primary CNS lymphoma as novel diagnostic biomarkers.

Ann Clin Transl Neurol, 5: 1611-1616, 2018

13.Mukai M, Mizuta I, Ueda A, Nakashima D, Kushimura Y, Noto YI, Ohara T, Itoh K, Ando Y, Mizuno T:

A Japanese CADASIL patient with homozygous NOTCH3 p.Arg544Cys Mutation confirmed pathologically.

J Neurol Sci, 394: 38-40, 2018

14.Mukaino A, Minami H, Isomoto H, Hamamoto H, Ihara E, Maeda Y, Higuchi O, Okanishi T, Kokudo Y, Deguchi K, Sasaki F, Ueki T, Murata KY, Yoshida T, Kinjo M, Ogawa Y, Ido A, Matsuo H, Nakao K, Nakane S:

Anti-ganglionic AChR antibodies in Japanese patients with motility disorders.

J Gastroenterol, 53: 1227-1240, 2018

15.Mukaino A, Tsuda M, Yamashita S, Kosaka T, Wada K, Ando Y:

Cerebrotendinous xanthomatosis presenting with extensive cerebral cortex symptoms: A case report.

Clin Neurol Neurosurg, 174: 217-219, 2018

16.Naganuma M, Inatomi Y, Nakajima M, Ohta T, Yonehara T, Ando Y:

Is the occlusion site of the lenticulostriate artery identified on admission related to clinical prognosis in patients with lacunar stroke?

J Stroke Cerebrovasc Dis, 27: 2035-2042, 2018

17.Naganuma M, Inatomi Y, Nakajima M, Yonehara T, Ando Y:

The association between uric acid level and 3-month functional outcome in acute ischemic stroke patients treated with/without edaravone.

Cerebrovasc Dis, 45: 115-123, 2018

18.Nagao Y, Nakajima M, Hirahara T, Wada K, Terasaki T, Nagamine M, Ando Y:

Calcified cerebral embolism due to a calcified amorphous tumor.

J Stroke Cerebrovasc Dis, 27: e115-e116, 2018

19.Nakane S, Fujita K, Azuma S, Urushihara R, Kamada M, Harada, M, Izumi Y, Kaji R:

CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis.

Clin Neurol Neurosurg, 172: 162-168, 2018

20.Nakane S, Mukaino A, Higuchi O, Watari M, Maeda Y, Yamakawa M, Nakahara K, Takamatsu K, Matsuo H, Ando Y:

Autoimmune autonomic ganglionopathy: an update on diagnosis and treatment.

Expert Rev Neurother, 18: 953-965, 2018

21.Nishi S, Hoshino J, Yamamoto S, Goto S, Fuji H, Ubara Y, Motomiya Y, Morita H, Takaichi K, Yamagata K, Shigematsu T, Ueda M, Ando Y:

Multicentre cross-sectional study for bone-articular lesions associated with dialysis related amyloidosis in Japan.

Nephrology, 23: 640-645, 2018

22.Okada M, Ueyama H, Ishizaki M, Maeda Y, Yamashita S, Ando Y:

Long-term effects of edaravone on patients with amyotrophic lateral sclerosis.

eNeurologicalSci, 11: 11-14, 2018

23.Okuda Y, Yamada T, Ueda M, Ando Y:

First nationwide survey of 199 patients with amyloid A amyloidosis in Japan.

Intern Med, 57: 3351-3355, 2018

24.Sekijima, Y, Yazaki M, Ueda M, Koike H, Yamada M, Ando Y:

First Nationwide Survey on Wild-type ATTR Amyloidosis in Japan.

Amyloid, 25: 8-10, 2018

25.Shimazaki C, Hata H, Iida S, Ueda M, Katoh N, Sekishima Y, Ikeda S, Yazaki M, Fukushima W, Ando Y:

Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan.

Intern Med, 57: 181-187, 2018

26.Shinriki S, Jono H, Maeshiro M, Nakamura T, Guo J, Li JD, Ueda M, Yoshida R, Shinohara M, Nakayama H, Matsui H, Ando Y:

Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.

J Pathol, 244: 367-379, 2018

27.Shirahama R, Ono T, Nagamatsu S, Sueta D, Takashio S, Chitose T, Fujisue K, Sakamoto K, Yamamoto E, Izumiya Y, Kaikita K, Hokimoto S, Hori M, Harada-Shiba M, Kajiwara I, Ogawa H, Tsujita K:

Coronary Artery Plaque Regression by a PCSK9 Antibody and Rosuvastatin in Double-heterozygous Familial hypercholesterolemia with an LDL Receptor Mutation and a PCSK9 V4I Mutation.

Internal Medicine, 57: 3551-3557, 2018

28.Takamatsu K, Nakane S, Suzuki S, Kosaka T, Fukushima S, Kimura T, Miyashita A, Mukaino A, Yamakawa S, Watanabe K, Jinnin M, Komohara Y, Ihn H, Ando Y:

Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia.

Ann Clin Transl Neurol, 5: 1421-1427, 2018

29.Takashio S, Yamamuro M, Izumiya Y, Hirakawa K, Marume K, Yamamoto M, Ueda M, Yamashita T, Ishibashi-Ueda H, Yasuda S, Ogawa H, Ando Y, Anzai T, Tsujita K:

Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis.

ESC Heart Fail, 5: 27-35, 2018

30.Tawara N, Yamashita S, Kawakami K, Kurashige T, Zhang Z, Tasaki M, Yamamoto Y, Nishikami T, Doki T, Zhang X, Matsuo Y, Kimura E, Tawara A, Maeda Y, Hauschka SD, Maruyama H, Ando Y:

Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions.

Exp Neurol, 309: 169-180, 2018

31.Tomichi Y, Kawano H, Mukaino A, Chiba A, Doi Y, Arakawa S, Ishimatsu T, Fukae S, Abiru N, Maemura K:

Postural Orthostatic tachycardia in a Patient with Type 2 Diabetes with Diabetic Neuropathy.

Int Heart J, 59: 1488-1490, 2018

32.Tsuda Y, Yamanaka K, Toyoshima R, Ueda M, Masuda T, Misumi Y, Ogura T, Ando Y:

Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening.

Sci Rep, 8:17884, 2018

33.Watari M, Nakane S, Mukaino A, Nakajima M, Mori Y, Maeda Y, Masuda T, Takamatsu K, Kouzaki Y, Higuchi O, Matsuo H, Ando Y:

Autoimmune postural orthostatic tachycardia syndrome.

Ann Clin Transl Neurol, 28: 486-492, 2018

34.Yamamoto H, Hashimoto T, Kawamura S, Hiroe M, Yamashita T, Ando Y, Yokochi T:

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.

J Med Case Rep, 12: 370, 2018

35.Yamashita S, Nakama T, Ueda M, Honda S, Kimura E, Konagaya M, Ando Y:

Tongue strength in patients with subacute myelo-optico-neuropathy.

J Clin Neurosci, 47: 84-88, 2018

36.Yamashita T, Ueda M, Misumi Y, Masuda T, Nomura T, Tasaki M, Takamatsu K, Sasada K, Obayashi K, Matsui H, Ando Y:

Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.

J Neurol, 265: 134-140, 2018

37.Ami D, Mereghetti P, Foli A, Tasaki M, Milani P, Nuvolone M, Palladini G, Merlini G, Lavatelli F, Natalello A:

ATR-FTIR spectroscopy supported by multivariate analysis for the characterization of adipose tissue aspirates from patients affected by systemic amyloidosis.

Anal Chem, 91: 2894-2900, 2019

38.Conceição I, Damy T, Romero M, Galán L, Attarian S, Luigetti M, Sadeh M, Sarafov S, Tournev I, Ueda M:

Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations.

Amyloid, 26: 3-9, 2019

39.Doki T, Yamashita S, Wei FY, Hara K, Yamamoto T, Zhang Z, Zhang X, Tawara N, Hino H, Uyama E, Kurashige T, Maruyama H, Tomizawa K, Ando Y:

Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy.

Lab. Invest, 99: 1728-1740, 2019 

40.Endo Y, Hasegawa K, Nomura R, Arishima H, Kikuta K, Yamashita T, Inoue Y, Ueda M, Ando Y, Wilson M, Hamano T, Nakamoto Y, Naiki H:

Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy.

Acta Neuropathol Commun, 7: 12, 2019

41.Hirakawa K, Takashio S, Marume K, Yamamoto M, Hanatani S, Yamamoto E, Sakamoto K, Izumiya Y, Kaikita K, Oda S, Utsunomiya D, Shiraishi S, Ueda M, Yamashita T, Yamashita Y, Ando Y, Tsujita K:

Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.

ESC Heart Fail, 6: 122-130, 2019

42.Kameyama H, Uchimura K, Yamashita T, Kuwabara K, Mizuguchi M, Hung SC, Okuhira K, Masuda T, Kosugi T, Ohgita T, Saito H, Ando Y, Nishitsuji K:

The Accumulation of Heparan Sulfate S-Domains in Kidney Transthyretin Deposits Accelerates Fibril Formation and Promotes Cytotoxicity.

Am J Pathol, 189: 308-319, 2019

43.Kurisaki R, Ueyama H, Maeda Y, Sakamoto T, Nakahara K, Nakane S, Yamashita S, Ando Y, 2016 Kumamoto Earthquake PD Study Group:

Impact of major earthquakes on Parkinson’s disease.

J Clin Neurosci, 61: 130-135, 2019

44.Masuda T, Ueda M, Misumi Y, Nomura T, Inoue Y, Isoguchi A, Kanenawa K, Tasaki M, Yamashita T, Sonoda Y, Obayashi K, Ando Y:

Reduced intraepidermal nerve fiber density in patients with hereditary transthyretin amyloidosis.

Amyloid, 26: 79-80, 2019

45.Mitsutake A, Sato T, Katsumata J, Seki T, Maekawa R, Hideyama T, Kishida Y, Masuda T, Ando Y, Shiio Y:

The first Japanese case of biopsy‐confirmed small‐fiber neuropathy related to celiac disease.

Neurology and Clinical Neuroscience, 7: 31-33, 2019

46.Nagao Y, Nakajima M, Yamashita T, Ando Y:

Bilateral dropped hands in a patient with systemic lupus erythematosus.

Neurol Clin Neurosci, 7: 153, 2019

47.Nakajima M, Takeuchi T, Nagao N, Masuda T, Yamashita T, Yonehara T, Terasaki T, Ando Y:

Comparison of clinical features in transient focal neurological episodes between hereditary transthyretin type and Aβ type cerebral amyloid angiopathy.

Amyloid, 26: 81-82, 2019

48.Nakamura M, Misumi Y, Nomura T, Oka W, Isoguchi A, Kanenawa K, Masuda T, Yamashita T, Inoue Y, Ueda M, Ando Y:

Extreme adhesion activity of amyloid fibrils induces subcutaneous insulin resistance.

Diabetes, 68: 609-616, 2019

49.Nakase T, Yamashita T, Matsuo Y, Nomura T, Sasada K, Masuda T, Misumi Y, Takamatsu K, Oda S, Furukawa Y, Obayashi K, Matsui H, Ando Y, Ueda M:

Hereditary ATTR amyloidosis with cardiomyopathy caused by the novel variant transthyretin Y114S (p.Y134S).

Intern Med, 58: 2695-2698, 2019  

50.Obayashi K, Masuda T, Tasaki M, Ando Y, Ueda M:

Evaluation of myoelectrical activities of descending colon by electrointestinogram in patients with ATTRm amyloidosis.

Amyloid, 26: 66, 2019

51.Obayashi K, Masuda T, Tasaki M, Ando Y, Ueda M:

Serum diacron-reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP) in patients with ATTR-PN.

Amyloid, 26: 65, 2019

52.Oda S, Emoto T, Nakaura T, Kidoh M, Utsunomiya D, Funama Y, Nagayama Y, Takashio S, Tsujita K, Ueda M, Yamashita T, Ando Y, Yamashita Y:

Myocardial late iodine enhancement and extracellular volume quantification with dual-energy cardiac computed tomography using a dual-layer spectral detector system.

Radiology: Cardiothoracic Imaging, 2019 in press.

53.Saruwatari K, Sato R, Nakane S, Sakata S, Takamatsu K, Jodai T, Mito R, Horio Y, Saeki S, Tomita Y, Sakagami T:

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.

Cancers (Basel), 11: 140, 2019

54.Sato K, Sakamoto K, Hashimoto Y, Hanzawa K, Sueta D, Kojima S, Fukuda M, Usuku H, Kihara F, Hosokawa H, Nagai Y, Nakajima M, Saito Y, Sakai K, Masunaga S, Tanaka S, Fujimoto K, Morihisa K, Noda K, Nishigami K, Nagata K, Fujisue K, Tabata N, Ando Y, Tsujita K, Ogawa H, Hokimoto S:

Risk Factors and the Prevalence of Deep Vein Thrombosis Post-Kumamoto Earthquake.

Circ J, 2019 in press.

55.Swuec P, Lavatelli F, Tasaki M, Paissoni C, Rognoni P, Maritan M, Brambilla F, Milani P, Mauri P, Camilloni C, Palladini G, Merlini G, Ricagno S, Bolognesi M:

Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain (AL) amyloidosis patient.

Nat Commun, 10: 1269, 2019

56.Takeuchi Y, Nakahara K, Nakajima M, Inoue Y, Matsumura R, Yamaguchi M, Katabuchi H, Ando Y:  

A 23-year-old woman with sudden-onset blindness of the right eye.

J Stroke Cerebrovasc Dis, 28: e12-e13, 2019

57.Tasaki M, Ueda M, Hoshii Y, Mizukami M, Matsumoto S, Nakamura M, Yamashita T, Ueda A, Misumi Y, Masuda T, Inoue Y, Torikai T, Nomura T, Tsuda Y, Kanenawa K, Isoguti A, Okada M, Matsui H, Obayashi K, Ando Y:

A novel age-related venous amyloidosis derived from EGF-containing fibulin-like extracellular matrix protein 1.

The Journal of Pathology, 247: 444-455, 2019

58.Yamashita S, Tawara N:

Determination of cN1A autoantibodies by cell-based immunofluorescence cytochemistry.

Methods Mol Biol, 1901: 89-94, 2019

59.Yamashita T, Ohnishi K, Ueda M, Masuda T, Inoue Y, Misumi Y, Ueda A, Obayashi K, Takeya M, Ando Y:

Transthyretin amyloid-related cerebral angiitis after liver transplantation.

Amyloid, 26: 11-12, 2019

60.Yamashita T, Ueda M, Misawa S, Inoue Y, Masuda M, Misumi M, Takamatsu K, Obayashi K, Kuwabara S, Ando Y:

Changes in nerve excitability indices in hereditary transthyretin amyloidosis.

Amyloid, 26: 9-10, 2019